Abstract: Mechanistic models are critical for our understanding of both within-host dynamics (i.e.,
Introduction

27
Understanding the specific interactions between a host's immune system and an infectious agent 28 can be critical for understanding population-level patterns of infection prevalence and the dynamics 29 of prevalence through time [1, 2] . Mechanistic models of within-host dynamics use mathematical 30 expressions to represent the processes of pathogen population growth and immune defenses that 31 fight against pathogen growth. These types of models have revealed key insights, especially this is due to their distinct immune responses [13, 14] . The much more effective adult response to infection involves rapid, substantial CD8+ cellular responses, whereas tadpoles' responses are
We fit models to these time-series data that embodied two assumptions about viral growth and two about the host's immune response. First, we fit models with exponential viral growth (% & , where %
97
is the density of virus within the host, ( is the per capita growth rate of the virus, and + is the 98 viral carrying capacity. In some models, + can be viewed as the viral titer above which the virus 99 kills the host [5] ; however, because we are modeling mean-field dynamics, we do not explicitly 100 account for virus-induced host mortality.
101
We then layer on possible immune system dynamics. 
113
where we define 9 1 = :1(<), such that, when no virus is present, the immune system stabilizes to 114 its homeostatic level of immune component density equal to 1(<).
115
Finally, we assume a mass-action attack rate of the immune system against the virus, which is a
116
Type I Hollings' functional response, such that our most complex model becomes:
119
Note that all of our models are therefore nested, and Table 1 shows all model formulations that we 120 fit to our data set. We divide the models into two classes, A and B, which are differentiated by the 121 assumptions about the immune system's growth dynamics. Class A models are mostly
122
distinguished by the fact that, at equilibrium, if the immune system response is strong enough, the 123 virus is driven extinct (i.e., full viral clearance). For Class B models, the virus is not driven extinct,
124
such that the virus persists at low levels within the hosts (Appendix A).
125
On a less technical note, in some ways our models are not specific about how the immune system of 
169
Thus, the scaling of the parameters does not change, just the scaling of the state variables. This also 170 allowed us to more reliably assume a Gaussian likelihood for log-transformed viral titer. We further 171 allowed the residual variance to be different for each dosage treatment.
rank-order of our models using model comparison, but it did generally make the models fit more poorly to the data, bringing down the average predicted titer and altering the marginal posterior estimates of the model parameters. We therefore do not consider these model fits further. We had trouble fitting model A1 to the data, because it fits so poorly to the low-dose treatment.
218
Therefore, the model ends up predicting a more or less linear decline in virus load across time, with 219 high variance ( Figure S1 ). This linear effect allowed the model to fit very well to the data from the 220 low dose treatment, increasing its overall likelihood and improving its LOO-IC value. However,
221
this parameterized version of the model fails to capture basic features of the data set. In contrast,
222
model A2 fits to the data reasonably well ( Figure S2 ). However, this model predicts the same peak 223 titer across dosage treatments, leading to a very poor fit to the data from the low-dose treatment. whether there is a rise and fall of viral load in individuals. Alternatively, it may be fruitful to 252 experiment with larger-bodied animals that would permit sampling blood repeatedly through time.
253
Our model also predicts that, if a host does not die from the initial exponential growth of the virus,
254
the immune system will decrease the virus to an endemic equilibrium (Appendix A). In other words,
255
we should see persistent infections with very low levels of virus in some infected bullfrog tadpoles.
256
It is worth noting that this model prediction is not relevant to quiescent virus persisting in particular 
312
Appendix A
313
The coexistence equilibrium of model B2, which analytically expresses the amount of virus and host
314
immune components at the stable equilibrium with a persistent infection, is as follows: 
